Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal H G Duijf

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Oncogenesis|May 16, 2021
Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumoursMadushan Fernando, Pascal H G Duijf, Martina Proctor, et al.
Cancers|March 6, 2021
COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic TargetAmila Suraweera, Pascal H G Duijf, Christian Jekimovs, et al.
Journal of Cellular Physiology|December 12, 2018
microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunitiesZahra Asadzadeh, Behzad Mansoori, Ali Mohammadi, et al.
Wiley Interdisciplinary Reviews. RNA|August 12, 2022
Noncoding RNAs in oral cancerJaikrishna Balakittnen, Chameera Ekanayake Weeramange, Daniel F Wallace, et al.
Advanced Pharmaceutical Bulletin|July 16, 2020
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1Solmaz Shirjang, Behzad Mansoori, Ali Mohammadi, et al.
Human Immunology|May 22, 2021
The impact of microRNAs on myeloid-derived suppressor cells in cancerElham Baghbani, Saeed Noorolyai, Pascal H G Duijf, et al.
Cancers|July 12, 2025
MicroRNAs in Cancer Immunology: Master Regulators of the Tumor Microenvironment and Immune Evasion, with Therapeutic PotentialErfan Zare, Seyyed Mohammad Yaghoubi, Maedeh Khoshnazar, et al.
Breast Cancer Research : BCR|November 28, 2024
Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug responseParastoo Shahrouzi, Youness Azimzade, Wioletta Brankiewicz-Kopcinska, et al.
Genes|March 6, 2021
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient PrognosisBehzad Mansoori, Nicola Silvestris, Ali Mohammadi, et al.
Frontiers in Immunology|March 8, 2021
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer PatientsElham Safarzadeh, Ali Mohammadi, Behzad Mansoori, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Oncogenesis|May 16, 2021
Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumoursMadushan Fernando, Pascal H G Duijf, Martina Proctor, et al.
Cancers|March 6, 2021
COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic TargetAmila Suraweera, Pascal H G Duijf, Christian Jekimovs, et al.
Journal of Cellular Physiology|December 12, 2018
microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunitiesZahra Asadzadeh, Behzad Mansoori, Ali Mohammadi, et al.
Wiley Interdisciplinary Reviews. RNA|August 12, 2022
Noncoding RNAs in oral cancerJaikrishna Balakittnen, Chameera Ekanayake Weeramange, Daniel F Wallace, et al.
Advanced Pharmaceutical Bulletin|July 16, 2020
miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1Solmaz Shirjang, Behzad Mansoori, Ali Mohammadi, et al.
Human Immunology|May 22, 2021
The impact of microRNAs on myeloid-derived suppressor cells in cancerElham Baghbani, Saeed Noorolyai, Pascal H G Duijf, et al.
Cancers|July 12, 2025
MicroRNAs in Cancer Immunology: Master Regulators of the Tumor Microenvironment and Immune Evasion, with Therapeutic PotentialErfan Zare, Seyyed Mohammad Yaghoubi, Maedeh Khoshnazar, et al.
Breast Cancer Research : BCR|November 28, 2024
Loss of chromosome cytoband 13q14.2 orchestrates breast cancer pathogenesis and drug responseParastoo Shahrouzi, Youness Azimzade, Wioletta Brankiewicz-Kopcinska, et al.
Genes|March 6, 2021
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient PrognosisBehzad Mansoori, Nicola Silvestris, Ali Mohammadi, et al.
Frontiers in Immunology|March 8, 2021
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer PatientsElham Safarzadeh, Ali Mohammadi, Behzad Mansoori, et al.
Pageof 8